Lingang Blue Bay Capital
Overview
-
Portfolio Companies
6
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Edge Medical Robotics | Nov 2021 | Series C | Co-investor |
| Kactus Biosystems | Oct 2022 | Series B | Co-investor |
| Shanghai Desano Pharmaceutical Group Co., Ltd. | Mar 2022 | Series A Extension | Co-investor |
| Sanegene Bio | Dec 2023 | Series A Extension | Co-investor |
| Zencore Biologics | Aug 2022 | Series C Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lingang Blue Bay Capital based?
Headquarters information for Lingang Blue Bay Capital is not publicly available.
When was Lingang Blue Bay Capital founded?
Founding year information for Lingang Blue Bay Capital is not publicly available.
How many portfolio companies does Lingang Blue Bay Capital have?
Lingang Blue Bay Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in Lingang Blue Bay Capital's portfolio?
Portfolio companies visible on Caplight include Edge Medical Robotics, Kactus Biosystems, Shanghai Desano Pharmaceutical Group Co., Ltd., Sanegene Bio, Zencore Biologics.
What was Lingang Blue Bay Capital's most recent investment shown here?
Lingang Blue Bay Capital's most recent investment in this portfolio sample was in Sanegene Bio in 2023.
What sectors does Lingang Blue Bay Capital focus on?
Lingang Blue Bay Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Lingang Blue Bay Capital focus on?
Lingang Blue Bay Capital typically invests at the Early stage.